Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality? | Am J Dermatopathol;44(1): 80-82, 2022 01 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?

Ungari, Marco; Pezzarossa, Enrico.

Ungari M; Departments of Pathology, and.
Pezzarossa E; Dermathology, A.S.S.T. Cremona, Cremona, Italy.

Am J Dermatopathol ; 44(1): 80-82, 2022 01 01.

Article in English | MEDLINE | ID: covidwho-1494040

Subject(s)

COVID-19/prevention & control; ChAdOx1 nCoV-19/adverse effects; Vasculitis/etiology; Humans; Male; Middle Aged; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vasculitis / COVID-19 / ChAdOx1 nCoV-19 Type of study: Case report Topics: Vaccines Limits: Humans / Male / Middle aged Language: English Journal: Am J Dermatopathol Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vasculitis / COVID-19 / ChAdOx1 nCoV-19 Type of study: Case report Topics: Vaccines Limits: Humans / Male / Middle aged Language: English Journal: Am J Dermatopathol Year: 2022 Document Type: Article